The blockbuster GLP-1 drugs that person reshaped the attraction of diabetes and obesity whitethorn assistance forestall aggregate substance usage disorders — and trim the tragic outcomes they cause, a ample caller survey finds.
An investigation published Wednesday successful a aesculapian diary looked astatine physics wellness records from much than 600,000 U.S. Veterans Affairs patients with diabetes. It recovered that those treated with medications specified arsenic Ozempic and Mounjaro were little apt to make addictions to alcohol, nicotine, cocaine, opioids and different substances than those treated with a antithetic people of drugs.
In those already addicted, the GLP-1 drugs were linked to little risks of hospitalization, overdose and death, according to the study.
The caller results suggest — but don’t beryllium — that the weight-loss medications whitethorn beryllium capable to people the underlying root of cravings that impact the much than 48 cardinal Americans with substance usage disorders.
“They're really moving against the basal origin of each these antithetic addictions,” said Dr. Ziyad Al-Aly, the study’s pb writer and a main researcher astatine the VA St. Louis Health Care System.
Here’s what you request to cognize astir the caller probe published by The BMJ:
Previous studies person suggested that the drugs known arsenic GLP-1s, oregon glucagon-like peptide-1 receptor agonists, could trim addictions by targeting the brain's reward pathways. But those studies person been tiny and often constricted to 1 substance.
For this study, 1 of the largest to date, Al-Aly and his colleagues analyzed information from the physics records of much than 600,000 Veterans Affairs patients with diabetes implicit 3 years. They compared radical who received GLP-1 drugs with those treated with medications that little humor sugar.
The patients were divided into 7 parallel trials that analyzed the hazard of processing addictions to aggregate substances including alcohol, cannabis, cocaine, nicotine and opioids. Another proceedings looked astatine the hazard of circumstantial harms among radical with existing addictions erstwhile they took the antithetic types of medication.
Al-Aly and his colleagues recovered that radical starting the GLP-1 drugs had little risks of processing addiction to aggregate substances. Compared with the different medications, radical taking the GLP-1 drugs had a reduced hazard for addiction: 18% for alcohol, 14% for cannabis, 20% for some cocaine and nicotine, and 25% for opioids.
In patients who already had substance usage disorders, starting the GLP-1s was linked with a 31% little hazard of exigency section visits, 26% little hazard of hospitalizations, 25% little hazard of suicidal thoughts oregon attempts, 39% little hazard of overdose — and 50% little hazard of death.
Overall, the survey recovered that utilizing GLP-1 drugs apt prevented astir 7 cases of substance usage upset and 12 incidents involving superior harm for each 1,000 users implicit 3 years, Al-Aly said.
Among the study's limitations: It was conducted wrong the VA wellness system, which serves a colonisation that is mostly older, achromatic and male, though Al-Aly said the results were accordant successful much than 35,000 women. It besides includes information lone from radical with diabetes, not the wide population.
The researchers besides couldn't relationship for immoderate factors, specified arsenic socioeconomic presumption oregon manner choices, that could impact the results. And the investigation focuses connected the effects of utilizing GLP-1s compared with different drug, not compared with nary treatment.
As an observational study, the caller investigation showed that the GLP-1s are associated with reduced hazard of substance usage disorders and harms, not that the drugs themselves caused the reduction.
The caller findings are striking, said Dr. Lorenzo Leggio, a National Institute connected Drug Abuse objective manager who wasn't progressive successful the study.
“Even though we don't afloat recognize the mechanism, someway the GLP-1 strategy is tackling addiction biology and the foundational strategy that underlies each these disorders,” helium said.
Diabetes and weight-loss trials person shown that the GLP-1 drugs people hormones successful the gut and the encephalon that power appetite and feelings of fullness, cutting down connected what's described arsenic “food noise,” oregon intrusive thoughts of food. In the aforesaid way, this survey indicates the drugs whitethorn tamp down “alcohol oregon cause noise,” Leggio said.
Growing grounds that GLP-1s mightiness forestall substance usage disorders is exciting, said Dr. Anna Lembke, a Stanford University addiction medicine specialist.
“We haven't truly had a caller instrumentality successful our toolbox from a pharmacotherapy position to dainty addiction successful a agelong time,” said Lembke, noting that immoderate addiction specialists are already prescribing GLP-1s off-label, particularly erstwhile different treatments person failed.
She cautioned that the GLP-1 drugs don't enactment the aforesaid mode for each users and that they person risks that indispensable beryllium weighed against imaginable benefits.
The caller findings bash not, by themselves, warrant prescribing GLP-1 drugs to forestall oregon dainty substance usage disorders, Al-Aly said. That grounds would request to travel from randomized controlled objective trials that straight comparison the usage of the drugs against a placebo, oregon dummy medication. Several specified trials are pending, Leggio noted.
The extremity is uncovering a caller mode to dainty addictions, which are a starring origin of sickness and decease astir the world.
“The effect successful presumption of chronic illness of these addictive drugs is really gigantic successful our society,” Leggio said.
___
The Associated Press Health and Science Department receives enactment from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely liable for each content.
English (CA) · 
English (US) · 
Spanish (MX) ·